Phylogica's exciting in-house drug candidates that they've been developing i.e., Neuroprotective peptide inhibitors is something I believe we'll be hearing a lot more about over the coming months.
Note, they are currently in discussions with a "number" of Pharmaceutical companies around potential licensing. Interesting how Nick Woolf mentioned this in the interview.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
-0.075(5.28%) |
Mkt cap ! $787.4M | |||
| Open | High | Low | Value | Volume |
| $1.42 | $1.42 | $1.34 | $553.4K | 405.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 2406 | $1.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.35 | 96533 | 2 |
View Market Depth
| Last trade - 14.11pm 23/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |